And tardiness has always been an issue, and as you point out with their predecessors particularly But most investors would rather get an partial dataset insight earlier than planned with this lot at Q1 2024, than nothing but a failure to produce a full dataset insight at 1H 2024 with the old exec;s.
These lot are keener to get at least partial data out to market. I'd rather that than the crickets we heard with the previous leadership - bar eventual updates on delayed recruitment.
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-7
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.025(8.62%) |
Mkt cap ! $47.60M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 26.5¢ | $30.17K | 112.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28895 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |